What values do the public want their health care systems to use in evaluating technologies?

by Buxton, Martin J., Chambers, James D.
Published 2011

30 years of media coverage on high drug prices in the US – a never-ending story or a time for change?

by Leopold, Christine, Chambers, James D, Wagner, Anita K
Published in J Pharm Policy Pract (2015)

Variation in health plan specialty drug coverage: an empirical analysis

by Margaretos, Nikoletta M., Lai, Rachel C., Panzer, Ari D., Chambers, James D.
Published in J Drug Assess (2019)

Orphan Drugs Offer Larger Health Gains but Less Favorable Cost-effectiveness than Non-orphan Drugs

by Chambers, James D., Silver, Madison C., Berklein, Flora C., Cohen, Joshua T., Neumann, Peter J.
Published in J Gen Intern Med (2020)

Coverage for Biosimilars vs Reference Products Among US Commercial Health Plans

by Chambers, James D., Lai, Rachel C., Margaretos, Nikoletta M., Panzer, Ari D., Cohen, Joshua T., Neumann, Peter J.
Published in JAMA (2020)

EXAMINING EVIDENCE IN U.S. PAYER COVERAGE POLICIES FOR MULTI-GENE PANELS AND SEQUENCING TESTS

by Chambers, James D., Saret, Cayla J., Anderson, Jordan E., Deverka, Patricia A., Douglas, Michael P., Phillips, Kathryn A.
Published in Int J Technol Assess Health Care (2017)

Payer coverage policies for multigene tests

by Phillips, Kathryn A, Deverka, Patricia A, Trosman, Julia R, Douglas, Michael P, Chambers, James D, Weldon, Christine B, Dervan, Andrew P
Published in Nat Biotechnol (2017)

An Assessment of the Methodological Quality of Published Network Meta-Analyses: A Systematic Review

by Chambers, James D., Naci, Huseyin, Wouters, Olivier J., Pyo, Junhee, Gunjal, Shalak, Kennedy, Ian R., Hoey, Mark G., Winn, Aaron, Neumann, Peter J.
Published in PLoS One (2015)

Correction: An Assessment of the Methodological Quality of Published Network Meta-Analyses: A Systematic Review

by Chambers, James D., Naci, Huseyin, Wouters, Olivier J., Pyo, Junhee, Gunjal, Shalak, Kennedy, Ian R., Hoey, Mark G., Winn, Aaron, Neumann, Peter J.
Published in PLoS One (2015)

How Do Payers Respond to Regulatory Actions? The Case of Bevacizumab

by Dusetzina, Stacie B., Ellis, Shellie, Freedman, Rachel A., Conti, Rena M., Winn, Aaron N., Chambers, James D., Alexander, G. Caleb, Huskamp, Haiden A., Keating, Nancy L.
Published in J Oncol Pract (2015)

Insurance coverage for genomic tests

by Phillips, Kathryn A., Trosman, Julia R., Deverka, Patricia A., Quinn, Bruce, Tunis, Sean, Neumann, Peter J., Chambers, James D., Garrison, Louis P., Douglas, Michael P., Weldon, Christine B.
Published in Science (2018)

The Decline in Vitamin Research Funding: A Missed Opportunity?

by Chambers, James D, Anderson, Jordan E, Salem, Mark N, Bügel, Susanne G, Fenech, Michael, Mason, Joel B, Weber, Peter, West, Keith P, Wilde, Parke, Eggersdorfer, Manfred, Booth, Sarah L
Published in Curr Dev Nutr (2017)